For Figure 3 (page 995), compound TMC435350 is in Phase I and not in Phase II.
Also, the acknowledgements should read:
The authors would like to thank R. Douglas and L. O'Mahony for help in preparing the manuscript; this support was funded by Novartis. M.P.M., J.K.R., S.Z. acknowledge the support of Hep-Net, a network sponsored by BMBF, and M.P.M., S.Z., F.Z. are supported by VIRGIL, an EU6 Framework Project.
Additional information
The online version of the original article can be found at 10.1038/nrd2411
Rights and permissions
About this article
Cite this article
Manns, M., Foster, G., Rockstroh, J. et al. Erratum: The way forward in HCV treatment — finding the right path. Nat Rev Drug Discov 7, 102 (2008). https://doi.org/10.1038/nrd2498
Issue Date:
DOI: https://doi.org/10.1038/nrd2498
